Product news

Share this article:
FDA has approved an NDA for LoSeasonique, an oral contraceptive manufactured by Duramed, a subsidiary of Barr Pharmaceuticals.
 
Eli Lilly & Co. has announced the introduction of a color differentiation system for U-100 insulin products marketed in the US, including vials, pens and individual packaging for Humalog and Humulin
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters